Morgan Stanley Maintains Overweight on Healthpeak Properties, Lowers Price Target to $18
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and lowers the price target from $21 to $18.
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and lowers the price target from $21 to $18.